How effective is Aromasin for treating hormone receptor-positive breast cancer?

Aromasin (exemestane) has been shown to help reduce the risk of cancer recurrence in hormone receptor-positive breast cancer, particularly in postmenopausal women when used after initial treatment with other therapies like tamoxifen.

Overview

Women with hormone receptor-positive (HR+) breast cancer often seek long-term therapies to reduce recurrence. Aromasin is one medication used during or after other hormone-based treatments.

• It is a type of aromatase inhibitor taken after menopause.
• Studies suggest it may delay disease progression when taken as part of an extended treatment plan.
• This overview helps explain how Aromasin works, its approved uses, and how to access it safely.

Here’s how it fits into treatment and how effective it may be.

Detailed Information

How it works

Aromasin works by lowering estrogen levels in the body, which can help slow or stop the growth of hormone-sensitive tumors. It helps block the aromatase enzyme that the body uses to make estrogen, especially important after menopause when ovaries no longer produce it.

Clinical applications

Aromasin is used primarily in postmenopausal women with early or advanced HR+ breast cancer. It is often prescribed after 2–3 years of tamoxifen to continue estrogen suppression. This extended approach may help reduce the risk of cancer returning after initial therapy.

Safety and Effectiveness

Safety profile

The official prescription information lists common side effects such as hot flashes, fatigue, joint pain, and bone thinning. It should be used with caution in patients with liver or kidney problems, and periodic monitoring is recommended.

FDA approval and indications

Aromasin is FDA-approved for use in certain stages of HR+ breast cancer in postmenopausal women. It is licensed for use after tamoxifen therapy or in cases of advanced disease when other treatments are no longer effective.

Access and Availability

How to obtain safely

IsraelPharm offers international access to Aromasin at competitive rates. A valid prescription is required, and customers are encouraged to consult their healthcare provider to ensure it’s the right choice for their treatment plan.

Key Takeaways

• Aromasin is a postmenopausal hormonal therapy for HR+ breast cancer.
• It reduces estrogen levels that fuel cancer cell growth.
• Often used after tamoxifen to prolong treatment benefits.
• Has known side effects and requires regular monitoring.
• Available through licensed international pharmacies like IsraelPharm.

FAQ

What is the main benefit of taking Aromasin after tamoxifen?

Continuing treatment with Aromasin after completing tamoxifen may help lower the chance of breast cancer recurrence by further reducing estrogen levels.

How long do I need to take Aromasin?

The length of therapy varies, but it is often prescribed for 2–5 years following tamoxifen. Your provider will determine the right duration for your individual case.

Is Aromasin more effective than tamoxifen?

They work in different ways. While tamoxifen blocks estrogen receptors, Aromasin reduces estrogen production. Some research suggests extended therapy with Aromasin after tamoxifen may offer added benefit.

Can I take Aromasin if I’m premenopausal?

Aromasin is approved for use only in postmenopausal women. Premenopausal women usually require different hormone therapy depending on ovarian function.

Is Aromasin covered or affordable internationally?

International pharmacies like IsraelPharm offer Aromasin at lower prices than some local pharmacies. Always compare prices and ensure a valid prescription is used.